First U-M patient receives newly FDA-approved stem cell therapy for sickle cell anemia

Elijah Dottery, 10, underwent several treatments, including a bone marrow transplant, for his condition

5:00 AM

Author | Ananya Sen

little boy with basketballs and Michigan C.S. Mott logo behind him
Elijah Dottery underwent treatment for sickle cell anemia at C.S. Mott Children’s Hospital. Photos by Rasheka Williams

Sickle cell disease affects about 100,000 people in the United States and millions worldwide. It's a genetic condition that changes the shape of red blood cells from round and flexible to crescent shaped and rigid.

These sickle cells can get stuck in small blood vessels, leading to pain and a shortage of red blood cells, which results in anemia.

Elijah Dottery, now 10, was diagnosed with sickle cell anemia at birth. He had a family history of the condition—his father’s uncle had sickle cell disease, and his mother’s family had a history of the sickle cell trait.

“We were devastated to learn about his condition,” said Rasheka Williams, Elijah’s mother. “When he was a baby, we had to figure out if he was uncomfortable because he was hungry or wet or whether he was in crisis.”

Sickle cell pain crisis is spontaneous and unpredictable. It requires constant pain management, which in Elijah’s case involved taking medication every 4-6 hours during each episode.

He describes his pain as akin to being stabbed or feeling like his body was broken.

In April 2022, Elijah experienced constant stomach pain, prompting his mother to take him to the emergency department in Saginaw, Mich. Initially the doctors assumed that the pain was due to improper diet.

It was 2 a.m. and I Googled the best hospital in Michigan. University of Michigan Health came up, and we drove over an hour to the hospital.” 

The pain continued to recur every few weeks, even though his family was careful with Elijah’s food habits.

One night, Elijah woke up in extreme pain. Desperate for answers, his mother looked for other hospitals she could take Elijah to.

“It was 2 a.m. and I Googled the best hospital in Michigan,” Williams said. “University of Michigan Health came up, and we drove over an hour to the hospital.”

A CT scan at the U-M emergency department revealed that Elijah had stones in his gall bladder. He was scheduled for surgery to have his gall bladder removed. Impressed with the care Elijah was given, his family decided to transfer his ongoing sickle cell anemia treatment to U-M Health.

Elijah initially used patient-controlled analgesia, or PCA, pumps to manage his pain crisis. These pumps allowed him to administer opioids that helped reduce his pain and shorten his hospital stays.

Undergoing a marrow transplant for sickle cell anemia

The number of pain crisis episodes, however, continued.

During a hospital stay, Williams learned from one of Elijah’s nurses that sickle cell anemia could be treated with a bone marrow transplant. She scheduled a consultation with Ghada Abusin, M.D., Clinical Associate Professor of Pediatrics-Hematology Oncology and Blood and Marrow Transplant Specialist at U-M Heath C.S. Mott Children’s Hospital.

Usually, bone marrow transplant donors are siblings of the patient. Since Elijah is an only child, he underwent semi-standard transplant where his mother was his donor.

“It felt surreal because it felt like I was giving birth again and this time my donation would help provide him with a better life,” Williams said.

nfl football standing with little boy in hospital room
Elijah Dottery meeting Aidan Hutchinson.

Elijah received his bone marrow transplant in March 2025. Soon after, he developed complications from the transplant that included multiple fevers and graft-versus-host disease, or GvHD.

In GvHD, the donated cells (grafts) view the recipient’s cells (host) as an unfamiliar threat and attack them.

Elijah had an acute case affecting his skin and gastrointestinal tract, leaving him unable to eat and causing green liquid bowel movements.

Receiving FDA-approved stem cell therapy

Treatments for GvHD include steroids that weaken the immune system, preventing it from attacking the patient’s body.

When Elijah did not respond to any of his GvHD treatments, his care team decided to try mesenchymal stem cell therapy that had been approved by the FDA in December 2024.

Mesenchymal stem cells can differentiate into multiple types of cells. They help slow down the immune system to stop GvHD and repair injured tissues.

“We have given mesenchymal stem cells before, as part of compassionate use, and patients respond well,” Abusin said.

“Elijah was the first patient at U-M who received the treatment after FDA approval.”

Elijah completed his final stem cell therapy in January 2026.

During his treatment, he was also weaned off on the steroids he received.

Elijah inspires others with his story

Throughout his treatment journey, Elijah leaned on his faith and community.

During his stay at Mott, he met Detroit Lions #97 Aidan Hutchinson and was named Hutch’s Hero in December 2025 through Aidan Hutchinson’s foundation, House of Hutch.

Hutchinson later attended a Lions vs. Steelers game with Elijah’s mantra “faith over sickle” written across his water jug.

“Elijah was always graceful during his time here, even when it was difficult and frustrating,” Abusin said.

“His family kept their faith and were always optimistic. That made a big difference in his approach to the treatment.”


More Articles About:

Sickle Cell Anemia Children's Health C.S. Mott Children’s Hospital Cancer (Oncology) Blood Disorders (Hematology)
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

portrait of GHADA A ABUSIN

Ghada Ahmed Yousif Abusin, MD MS

Clinical Associate Professor

Related

doctor smiling window hallway sunlight
Health Lab

Living with sickle cell: From isolation to pursuing medical school, advocacy

Medical student shares journey with painful disease disproportionately affecting African Americans and why she wants to help others.
blood cells floating red maroon
Health Lab

Most babies with sickle cell disease face double disadvantage

Babies born with sickle cell disease face social inequality as well as a lifelong chronic disease that is often undertreated with proven drugs.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Child in blue shirt smiles on the green grass of a football field
Health Lab

FDA approved drug slows type 1 diabetes progression in 5-year-old patient

After a family history of type 1 diabetes led to early screening through TrialNet, 5-year-old Trevor became Michigan's youngest patient to receive delay-inducing drug TZIELD.
A group of costumed med students sing together outside an Ann Arbor storefront.
Philanthropy News

Galens Tag Days celebrates 100 years of helping kids

University of Michigan Medical Students are celebrating the 100th annual Galens Tag Days fundraiser for Washtenaw County children’s organizations.
Young boy in purple t-shirt sits smiling in the grass on a sunny day.
Health Lab

From 20 seizures a day to more time for play: How personalized epilepsy care helped young patient

Advanced genetic testing and a detailed diagnosis revealed infant’s rare epilepsy, leading to a non-conventional therapy.
Closeup of newborn baby, whose head is held by a blue medical gloved hand. Blue gloved hand also holds a stethoscope to baby's chest.
Health Lab

More babies with hypoplastic left heart syndrome surviving critical period between surgeries

Collaborative effort helped sustain improvements in survival for babies born with hypoplastic left heart syndrome (HLHS), a serious congenital heart condition that requires multiple surgeries.
Family of four poses with plain gray background behind them.
Health Lab

Type 1 diabetes does not mean sitting out for 10 year old

After an influenza infection, 8-year-old was diagnosed with type 1 diabetes at C.S. Mott Children’s Hospital. Read his journey from diagnosis to thriving with T1D.
Boy in white t-shirt, just chin showing, with hands holding a stethoscope on his chest.
Health Lab

Distance, insurance, social factors may hinder access to lifesaving heart monitoring for children

New research suggests that social, economic and geographic factors may influence whether patients who undergo the Fontan surgery for complex congenital heart disease receive the recommended lifelong cardiac monitoring.